Align Technology, Inc. with ticker code (ALGN) now have 11 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 440 and 270 calculating the mean target price we have $393.18. Given that the stocks previous close was at $358.66 and the analysts are correct then there would likely be a percentage uptick in value of 9.6%. Also worth taking note is the 50 day moving average now sits at $351.44 and the 200 day moving average is $297.60. The total market capitalization for the company now stands at 28.14B. The current share price for the company is: 367.62 USD
The potential market cap would be $30,843,261,407 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 88.58, revenue per share of 48.37 and a 6.02% return on assets.
Align Technology, Inc. is a medical device company. The Company is primarily engaged in the design, manufacture and marketing of Invisalign clear aligners for the treatment of malocclusions, or the misalignment of teeth, by orthodontists and general dental practitioners (GPs), Vivera retainers for retention, iTero intraoral scanners and services for dentistry, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software. It operates through two segments: Clear Aligner and Imaging Systems and CAD/CAM Services (Systems and Services). Its Clear Aligner segment consists of Comprehensive Products, which includes Invisalign Comprehensive and Invisalign First; Non-Comprehensive Products, which includes Invisalign Moderate, Lite and Express packages and Invisalign Go, and Non-Case products, which include retention products, Invisalign training, adjusting tools used by dental professionals. Its Systems and Services segment consists of iTero intraoral scanning systems.
